CNVI:CA files prospectus for equity offering to fund US market entry and working capital needs by May 28, 2026.
Conavi Medical (CNVI:CA) has filed a preliminary prospectus for an offering of common shares and/or pre-funded warrants. The company aims to raise capital to support a limited market release in the United States.
Proceeds will also be used for working capital and general corporate purposes. The offering is expected to close on or about May 28, 2026, pending regulatory approval and market conditions.
No details on the size or pricing of the offering were disclosed in the filing.